Balance Labs, Inc.
BLNC
$1.55
-$0.02-1.27%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 445.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 445.00% | -- | |||
| Cost of Revenue | -96.26% | 6,800.82% | |||
| Gross Profit | 96.52% | -6,797.54% | |||
| SG&A Expenses | -61.47% | 351.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -95.91% | 5,936.19% | |||
| Operating Income | 96.17% | -5,933.35% | |||
| Income Before Tax | 100.63% | -679.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 100.63% | -679.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 100.63% | -679.51% | |||
| EBIT | 96.17% | -5,933.35% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 100.51% | -356.85% | |||
| Normalized Basic EPS | 96.48% | -87.48% | |||
| EPS Diluted | 100.51% | -356.85% | |||
| Normalized Diluted EPS | 96.48% | -87.48% | |||
| Average Basic Shares Outstanding | 24.81% | 70.59% | |||
| Average Diluted Shares Outstanding | 24.99% | 70.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||